Company Filing History:
Years Active: 2013
Title: Kei Nagae: Innovator in Pyridazinone Compounds
Introduction
Kei Nagae is a prominent inventor based in Funabashi, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that target specific receptors involved in inflammatory and immunological diseases.
Latest Patents
Nagae holds a patent for pyridazinone compounds and P2X7 receptor inhibitors. This patent describes novel pyridazinone compounds of formula (I), which inhibit the purinergic P2X7 receptor. These compounds are useful for the prevention, therapy, and improvement of various inflammatory and immunological diseases.
Career Highlights
Nagae is associated with Nissan Chemical Industries Limited, where he has been instrumental in advancing research and development in pharmaceutical applications. His work has led to innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Nagae has collaborated with notable colleagues, including Yukihiro Shigeta and Yutaka Hirokawa. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Nissan Chemical Industries Limited.
Conclusion
Kei Nagae's contributions to the field of medicinal chemistry, particularly through his patent on pyridazinone compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of inflammatory and immunological diseases.